Cutler Group’s BioTelemetry, Inc. BEAT Stock Holding History

Cutler Group’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,500	Closed	-$2K	–	5112
2018 Q2	$2K	Hold	1,500	–	–	﹤0.01%	3726
2018 Q1	$13K	Buy	+1,500	New	+$49.3K	﹤0.01%	2620
2017 Q4	–	Sell	-1,500	Closed	-$3K	–	6675
2017 Q3	$3K	Buy	+1,500	New	+$52K	﹤0.01%	4974
2017 Q2	–	Sell	-9,000	Closed	-$1K	–	7702
2017 Q1	$1K	Sell	9,000 -9,800	-52%	-$243K	﹤0.01%	6228
2016 Q4	$55K	Sell	18,800 -5,300	-22%	-$104K	﹤0.01%	2451
2016 Q3	$110K	Buy	24,100 +20,300	+534%	+$383K	﹤0.01%	1732
2016 Q2	$10K	Buy	+3,800	New	+$55.9K	﹤0.01%	4229

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Cutler Group's BEAT Position: Q1 2020 in Review

Cutler Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 1,600 shares — an estimated $74K sold.

Cutler Group first reported a position in BEAT in Q1 2016 and held it in 11 quarters. The position peaked at $426K in Q2 2017. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

Cutler Group reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
Cutler Group sold 1,600 BioTelemetry, Inc. shares in Q1 2020, an estimated $74K.
Cutler Group first reported a position in BioTelemetry, Inc. in Q1 2016 and held it in 11 quarters.
Cutler Group's BioTelemetry, Inc. position peaked at $426K in Q2 2017.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.